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Background: Int22h1/int22h2-mediated Xq28 duplication syndrome is caused by ~0.5 Mb chromosomal duplications
mediated by nonallelic homologous recombination between intron 22 homologous region 1 (int22h1) and 2 (int22h2),
which, in addition to int22h3, are also responsible for inversions disrupting the F8 gene in hemophilia A. This syndrome
has recently been described in 9 males with cognitive impairment, behavioral problems, and distinctive facial features;
and 6 females with milder phenotypes. The reciprocal deletion was previously reported in a mother and daughter. It
was suggested that this deletion may not have phenotypic effects in females because of skewed chromosome X
inactivation, but may be embryonic lethal in males.
Methods: Array comparative genomic hybridization analyses were performed using oligonucleotide-based chromosomal
microarray. Chromosome X inactivation studies were performed at the AR (androgen receptor) and FMR1 (fragile X mental
retardation 1) loci.
Results: We present here 5 males and 6 females with int22h1/int22h2-mediated Xq28 duplication syndrome. The males
manifested cognitive impairment, behavioral problems, and distinctive facial features. Two of the six females manifested
mild cognitive impairment. This duplication was maternally inherited, and skewed chromosome X inactivation was
observed in the majority of females carrying the duplication. We also report the reciprocal deletion in a mother and
daughter with overweight, but normal cognition. In addition, we present the first case of a prenatally diagnosed de novo
int22h1/int22h2-mediated deletion in a healthy female infant. We reviewed individuals previously reported with similar or
overlapping rearrangements and evaluated the potential roles of genes in the rearrangement region.
Conclusions: The similarity of clinical features among individuals with the int22h1/int22h2-mediated Xq28 duplication
supports the notion that this duplication causes a recognizable syndrome that affects males with females exhibiting
milder phenotypes. It is suggested that the observed cognitive impairment in this syndrome results from increased
dosage of RAB39B gene located within the duplicated region. Increased dosage of CLIC2 may also contribute to the
phenotype. The reciprocal deletion results in skewed chromosome X inactivation and no clinical phenotype in females.
Review of overlapping deletions suggests that hemizygous loss of VBP1 may be the cause for the proposed male
lethality associated with this deletion.
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Intellectual disability (ID), which affects 2% of the popula-
tion, is diagnosed in individuals with significantly impaired
intellectual function (Intelligence Quotient (IQ) of 70 or
below), poor adaptive skills, and onset before 18 years of
age [1]. X-linked ID (XLID) is estimated to account for
10% of ID in males and thus has a prevalence of 1:1000
males [2]. Although XLID is most often caused by single-
gene defects, the use of array comparative genomic
hybridization (array CGH) has led to the identification of
chromosome X rearrangements in a significant number of
individuals with XLID [3]. Not only deletions, but also du-
plications in chromosome X can result in XLID, support-
ing the concept that increased gene dosage can disrupt
normal cognitive development. The most common XLID-
related chromosomal rearrangements are duplications of
Xq28 comprising the MECP2 gene (153.3 Mb, hg19),
which present with intellectual disability, distinctive facial
features, hypotonia, seizures, and recurrent infections
[4,5]. The detrimental effect of MECP2 duplication was
predicted by a mouse model in which Mecp2 overexpres-
sion resulted in a progressive neurological disorder resem-
bling the human disease [6].
We previously described a novel ~0.5 Mb duplication in
Xq28 (154.1 - 154.6 Mb, hg19) located telomeric to the
MECP2 locus and mediated by nonallelic homologous re-
combination between low-copy repeats (LCRs) intron 22
homologous region 1 (int22h1) and 2 (int22h2), which, in
addition to int22h3, are also responsible for inversions dis-
rupting the F8 gene in hemophilia A. This duplication was
identified in four males with cognitive impairment who
shared similar facial features, behavioral abnormalities,
and recurrent infections suggesting that this duplication
results in a novel recognizable XLID syndrome [7]. Subse-
quently, an identical duplication was described in a boy
with developmental delay, Pierre-Robin sequence, and dis-
tinctive facial features [8]. Recently, four additional males
with the same duplication were reported with cognitive
impairment, behavioral problems, and distinctive facial
features [9]. The frequency of int22h1/int22h2-mediated
Xq28 duplication has been estimated at 1:1000 among
males with ID [9]. These duplications were found to be
inherited from mothers with skewed chromosome X in-
activation (XCI) in the majority of the cases [7-9]. Clinical
similarities among the individuals described in these three
reports support that int22h1/int22h2-mediated Xq28 du-
plication results is a recognizable XLID syndrome.
The reciprocal int22h-1/int22h-2-mediated Xq28 dele-
tion was also first reported by us in a girl and her
mother both of whom exhibited normal cognition and
skewed XCI. In addition, the mother had two spontan-
eous miscarriages during first trimester. It was suggested
that this deletion has no phenotypic effect in females;
however, it may be embryonic lethal in males resultingin higher miscarriage rates in females carrying this dele-
tion [7].
In this report we describe 11 additional individuals
(5 males and 6 females) from five different families with
int22h1/int22h2-mediated Xq28 duplication. In addition,
we report two families with the reciprocal deletion. We
present a review of individuals reported with similar or
overlapping rearrangements and discuss the potential
roles of genes in the rearrangement region.
Methods
Array CGH
Array CGH analysis was performed at the Medical Genetics
Laboratories (MGL) at Baylor College of Medicine (BCM).
The study received the ethics approval from the Institu-
tional Review Board (IRB) of BCM. Written informed con-
sent approved by the IRB of BCM was obtained from the
participants or their parents or legal guardians in the case
of children to participate in the study and to publish the
clinical details and any accompanying images. A copy of
the written consents is available for review by the Editor of
this journal. Array CGH tests were performed using
oligonucleotide-based chromosomal microarray (CMA
OLIGO) either version 7 or 8. CMA OLIGO version 7
comprises approximately 105,000 oligonucleotides, which
cover the entire genome at an average resolution of 30 kb
with increased coverage at known disease loci. The array
also includes six regions of known polymorphic variants
[10,11]. CMA OLIGO version 8 compromises approxi-
mately 180,000 oligonucleotides, which cover the entire
genome at an average resolution of 30 kb with increased
coverage at known disease loci. Exonic coverage for 1,700
selected disease-causing genes and 670 probes for mito-
chondrial genome are also included [10,12].
Fluorescence in situ hybridization analyses
Confirmatory fluorescence in situ hybridization (FISH) ana-
lyses with bacterial artificial chromosome (BAC) clones were
performed on peripheral blood lymphocytes using standard
procedures following the detection of copy-number changes
via array CGH [13].
Chromosome X-inactivation studies
Chromosome X-inactivation (XCI) studies were per-
formed at the AR (androgen receptor) and FMR1 (fragile
X mental retardation 1) loci [7,14,15]. The XCI ratio was
calculated and inactivation ratios greater than 80:20 were
designated as skewed XCI, whereas ratios greater than
95:5 were considered as extremely skewed XCI [16].
Results
Clinical description
Herein, we describe the clinical features in the members
of families 1–5 with int22h-1/int22h-2-mediated Xq28
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int22h-1/int22h-2-mediated Xq28 deletion.
Family 1 includes a 9-month-old male infant and his
25-year-old mother. The boy was born at term with an
uncomplicated perinatal course and a birth weight of
3.3 kg. Shortly after birth, he was diagnosed with
esophageal atresia with tracheoesophageal fistula for
which he underwent surgical repair on the third day of
life. During early infancy he was noticed to be develop-
mentally delayed. At the age of 9 months he was unable
to sit unsupported, pull to stand, or crawl; but he bab-
bled, had a social smile, and was able to roll from front
to back. His medical history was significant for recurrent
episodes of upper respiratory tract infections. His phys-
ical examination demonstrated normal growth parame-
ters, phimosis, and distinctive facial features (Figure 1A).
His mother reported a personal history of learning dis-
ability with a need for special education. Her medical
history was significant for cardiac valvular disease and
scoliosis. She also had some distinctive facial features
(Figure 1B). The boy was the only child for his parents,
but had 5 maternal half siblings including a 5-year-old
half-sister with developmental delay and an 8-year-old
half-brother with developmental delay and attention def-
icit hyperactivity disorder (ADHD) (Table 1).
Family 2 includes two brothers and their mother. The
older brother was 9 years old with developmental delay
and behavioral problems. He was born at term with birth
weight of 3.6 kg. Prenatal sonogram showed polyhydram-
nios, otherwise the pregnancy was uncomplicated. During
the first year of life he was noticed to be developmentally
delayed. He required special education classes and also
had ADHD, aggressive behaviors (tantrums, hitting others
and self), disruptive behavior at school, and autistic
features. His medical history was significant for recurrent
otitis media, eczema, and allergic rhinitis. His physical
examination showed normal growth parameters, clinodac-
tyly, and distinctive facial features including high forehead
and broad nasal bridge. The younger brother was 6 years
old with developmental delay. He was born at term with
birth weight of 3.7 kg. As his brother, he was found to be
developmentally delayed during infancy. He started walk-
ing at 18 months and had his single words at 2 years. At
the of 6 years he was able to make 3–5 word sentences
but was not toilet trained. He required special education
and also had ADHD and aggressive behavior including
hitting others and throwing objects. His medical history
was significant for a small atrial septal defect, recurrent
otitis media with tympanostomy tube placement, myopia,
and astigmatism. His physical examination revealed nor-
mal growth parameters and distinctive facial features in-
cluding full nasal tip, broad nasal bridge, and full lower
lip. They had no other siblings. The mother was 35 years
old. She graduated high school and completed 2 years ofcollege with no history of learning difficulties or behav-
ioral problems (Table 1).
Family 3 includes a 15-year-old boy who was born at
term with uncomplicated perinatal course. During early
childhood, he gained his developmental milestones ap-
propriately. However, he was noticed to have learning
difficulties starting in kindergarten. Formal evaluations
showed dyslexia, dysgraphia, and impaired processing
speed. He had difficulties in writing and reading and re-
quired special education. His medical history was signifi-
cant for asthma, allergic rhinitis, and recurrent otitis
media with tympanostomy tubes placement and adeno-
tonsillectomy. His physical examination showed weight
and height just above the 99th percentiles and head cir-
cumference at 98th percentile. He also had clinodactyly,
mild kyphosis, and distinctive facial features including
upper eyelid fullness, tubular nose, and thick lower lip
(Table 1). He is the only child for his parents. His
mother is 50 years old and reported a personal history of
learning difficulties and dyslexia.
Family 4 includes a 12-year-old boy who was born at
term. Both his parents used illicit substances. Therefore, at
the age of 20 months, he was removed from his family and
adopted. Since early childhood, he was noticed to be de-
layed. His IQ was found to be 59 at the age of 11 years and
language evaluation revealed significant deficits in expres-
sive language. He required special education and was diag-
nosed to have ADHD and bipolar disorder. In addition, he
had impulsivity, irritability, and insomnia. His medical his-
tory was significant for recurrent otitis media and lower
respiratory tract infections during the first 6 years of life.
He also had asthma and allergic rhinitis. He had a 23-year-
old maternal half-brother who was healthy. His physical
examination revealed normal growth parameters, single
palmar crease, and distinctive facial features including long
eyelashes, upper eyelid fullness, smooth philtrum, dental
crowding, pointed chin, and tubular nose. His mother was
46 years old and reported to abuse drugs and to have psy-
chiatric illness (Table 1).
Family 5 includes three sisters and their mother. The
proband was the youngest sister who was 4 years old
and presented with right lower extremity hemihyperpla-
sia. She was born at term with birth weight of 3.4 kg.
During pregnancy, the mother developed gestational dia-
betes that was diet-controlled. At the age of 6 months,
the proband was noticed to have a longer right leg than
the left. Subsequent X-rays demonstrated longer right
femur and tibia when compared to the left side. She was
otherwise healthy. She did not show any features of
Beckwith-Wiedemann syndrome and methylation stud-
ies for Beckwith-Wiedemann syndrome were also nor-
mal. She had normal development and no behavioral
problems. Physical examination showed asymmetry of
lower extremities with the right leg fuller and longer
Figure 1 (See legend on next page.)
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Figure 1 Facial features in individuals with int22h-1/int22h-2-mediated Xq28 rearrangements. A: facial features of the proband in family 1,
including high forehead, sparse eyebrows and scalp hair, long eyelashes, upper eyelid fullness, broad and depressed nasal bridge, anteverted nares, and
long philtrum. B: facial features of the mother in family 1, including deep set eyes and thick lower lip. C: facial features of the youngest sister in family 5
including high forehead, full upper eyelid, broad nasal bridge, and thick lower lip. D: facial features of the middle sister in family 5 including high forehead,
full upper eyelid, broad nasal bridge, and thick lower lip. E: facial features of the oldest sister in family 5 including high forehead, full upper eyelid, and thick
lower lip. F: facial features of the mother in family 5 including high forehead, elongated face, full upper eyelid, and thick lower lip. G: facial features of the
proband in family 6, including high forehead, deep-set eyes, epicanthus, and broad nasal bridge.
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tinctive facial features were noticed (Figure 1C). The
middle sister was 6 years old who had learning difficul-
ties, ADHD, and visual processing deficits. She was
moved from 1st grade back to kindergarten and required
special tutoring. She had distinctive facial features
(Figure 1D). The oldest sister was 8 years old and had
normal development and excellent school performance.
She had distinctive facial features (Figure 1E). They did
not have other siblings. The mother was 39 years old
and has normal cognition with no learning difficulties.
She had a college degree. She had distinctive facial fea-
tures (Figure 1F) (Table 1).
Family 6 includes a girl and her mother. The proband
was an 11 year old female presented with overweight.
She was born at term with uncomplicated perinatal
course and birth weight of 3.7 kg. Her weight had been
above the 95th percentile ever since the age of 9 months.
She had normal development during infancy and early
childhood. She did not have any learning difficulties and
had an excellent school performance. Her medical his-
tory was significant for tympanostomy tube placement
at the age of 2 years. Previous evaluation included
methylation test for Prader-Willi syndrome, thyroid
function test, leptin level, melanocortin 4 receptor gene
sequencing, cortisol level, bone age, and HbA1c were all
normal. Her physical examination revealed a weight that
is about 4SD above the mean, height at the 90th percent-
ile, head circumference at the 95th percentiles, normal
hand and feet length, a single café au lait spot on her
back, and some distinctive facial features (Figure 1G).
She had a 17 year-old sister who is healthy and not over-
weight. Her mother who was 47 years old was healthy,
but overweight. The mother had a college degree and
reported no learning difficulties or psychiatric illnesses.
The mother had one spontaneous miscarriage at
12 weeks gestational age.
Family 7 includes a 3 month-old female infant who was
born at term with uncomplicated perinatal course. During
pregnancy, the mother underwent chorionic villus sam-
pling (CVS) for advanced maternal age and karyotype and
array CGH were performed. The proband was healthy
with normal physical examination. She had a healthy 2-
year-old brother. The mother was 37 years old with no
significant medical history.Array CGH and FISH analyses
The proband of family 1, the two brothers of family 2,
the probands of family 3 and 4, and the three sisters of
family 5 were all found to have ~0.5 Mb Xq28 duplica-
tions spanning from 154.1 to 154.6 Mb based on hg19
(153.7 - 154.2 Mb based on hg18) by array CGH and con-
firmed by FISH analysis. The mothers in families 1, 2, and
5 were also found to carry the same duplication by FISH
analysis. The mothers in families 3 and 4 were unavailable
for testing.
The proband of family 6 was found to have ~0.5 Mb
Xq28 deletion spanning from 154.1 to 154.6 Mb (hg19)
by array CGH and confirmed by FISH analysis. Her
mother was found to carry the same deletion by FISH
analysis. Her sister, maternal grandfather, and maternal
aunt were also tested and found not to carry the dele-
tion. Her maternal grandmother was deceased. The pro-
band of family 7 was found to carry the same ~0.5 Mb
Xq28 deletion by array CGH and confirmed by FISH
analysis on the CVS sample that was obtained prenatally.
Parental array CGH did not show the deletion indicating
that this deletion is de novo in the proband.
Chromosome X inactivation assay
The mother in family 1, the mother in family 2, and the
oldest sister and the mother in family 5 showed skewed
XCI, whereas the youngest and the middle sister in family 5
showed random XCI. The results of the XCI performed at
the AR locus were suggestive of preferential inactivation of
the chromosome X carrying the duplication in the mothers
of families 1 and 5. However, the XCI at the FMR1 locus re-
sults was suggestive that the normal chromosome X is pref-
erentially inactivated in the mothers in families 1, 2, and 5
(Table 2). Both the proband and her mother in family 6
showed 95% skewed patterns. The proband of family 7
showed 100% skewing.
Immunological work up
Because of the recurrent infections observed in the males
with Xq28 duplication, an immunological evaluation was
performed for the probands of families 1, 3, and 4 and the
two brothers in family 2. Immunological work up, which
included immunoglobulin levels (IgG, IgM, IgA), tetanus
toxoid antibody level, H. influenzae type b antibody level,
lymphocyte subset (T-cell, B-cells, NK cells) panel, and
















































4/4 1/3 1/1 - 2/4 - + - + - - - - + + + + 9/14 5/12
Long face 1/4 - 1/1 - 1/4 - - - - - - - - - - - + 3/14 1/12
Sparse
eyebrows
1/4 1/3 - - - - + - - - - - - - - - - 2/14 1/12
Long
eyelashes








2/4 - - - 1/4 - - + - - - - - - - - - 3/14 1/12
Broad nasal
bridge
3/4 1/3 1/1 - - - + - + + - - - + + - - 7/14 3/12
Anteverted
nares
- - 1/1 - 1/4 - + - - - - - - - - - - 3/14 -
Thin upper
lip
- - 1/1 - 1/4 - - - - - - - - - - - - 2/14 -
Thick
lower lip
3/4 1/3 - - - - - + - + - + - + + + + 5/14 6/12
Micro/
retrognathia
2/4 - 1/1 - - - - - - - - - - - - - - 3/14 -
Long
philtrum
- - 1/1 - 1/4 - + - - - - - - - - - - 3/14 -
Large ears - - 1/1 - 2/4 - - - - - - - - - - - - 3/14 -
Simple
helices
1/4 - - - 1/4 - - - - - - - - - - - - 2/14 -
Tall stature 1/4 - - - 1/4 - - - - - - + - - - - - 3/14 -
Obesity 2/4 1/3 - - 2/4 - - - - - - - - - - - - 4/14 1/12
Behavioral
problems














Table 1 Clinical features of individuals with int22h1/int22h2-mediated Xq28 duplication (Continued)
Recurrent
infections
4/4 - - - 1/4 - + - + + - + + - - - - 10/14 -










M: male, F: female, EA/TEF: esophageal atresia with tracheoesophageal fistula, ASD: atrial septal defect.














Table 2 Chromosome X inactivation in females with int22h1/int22h2-mediated Xq28 duplication
El-Hattab et al. 2011 (Ref [7]) Lannoy et al.
2013(Ref [8])
Vanmarsenille
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XCI Skewed Skewed Skewed Skewed Random Skewed Skewed Skewed Random Random Skewed Skewed




Ratio 89:11 88:12 NA 80:20 68:32 89:11 99:1 95:5 50:50 62:38 80:20 88:12





















































Allele 239 is shared among all
suggesting that this allele is the
duplicated chromosome and the
normal chromosome X (236) is
preferentially inactivated in the older
sister while the duplicated
chromosome X (239) is preferentially
inactivated in the mother.
FMR1 locus Allele size 380/281 308/278 314/308 293/328 322/328 322:325 322 322 328:322
Ratio 87:13 87:13 94:6 93:7 95:5 50:50 NA NA 81:19



















































Allele 322 is shared among all
suggesting this allele is the duplicated
chromosome and the normal
chromosome X (328) is preferentially
inactivated in the mother.
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veal any significant abnormalities.Discussion
The expanded use of high-resolution genome analysis by
array CGH has led to the identification of several new
microdeletion and microduplication syndromes [12,17].
Herein we present new families and review previously re-
ported ones with the newly described int22h1/int22h2-me-
diated Xq28 duplication syndrome. Before this report,
molecularly-confirmed int22h1/int22h2-mediated Xq28
duplications were described in only 15 individuals (Table 1)
[7-9]. In this report, we present 11 additional individuals
with int22h1/int22h2-mediated Xq28 duplication including
5 males and 6 females. The 5 cognitively impaired males
presented with behavioral problems, recurrent upper re-
spiratory tract infections, atopic diseases, and distinctive fa-
cial features. The 6 females exhibited a milder phenotype
with mild cognitive impairment in the form of learning dif-
ficulties in two, ADHD in one, and some distinctive facial
features similar to the affected males (Table 1).
The similarity of clinical features of the families in this
report with the previously reported families supports the
notion that int22h1/int22h2-mediated Xq28 duplication
causes a recognizable syndrome that affects males with
females exhibiting a milder phenotype. Cognitive impair-
ment occurs in all males with int22h1/int22h2-mediated
Xq28 duplication syndrome. Common features in males
are behavioral problems (ADHD and aggressiveness), re-
current upper respiratory tract infections, and distinctive
facial features (high forehead, long face, upper eyelid
fullness, deep seated eyes, broad nasal bridge, anteverted
nares, long philtrum, thick lower lip, microretrognathia,
and large ears). Less common features are obesity, tall
stature, and atopic diseases. Females manifest a milder
phenotype with cognitive impairment in the form of
learning difficulties being observed in the majority.
Minor distinctive facial features similar to affected males
can be observed. None of the females had recurrent in-
fections or atopic diseases. Only one girl was reported to
have ADHD. Several congenital malformations have
been sporadically described such as esophageal atresia
with tracheoesophageal fistula, Pierre-Robin sequence,
cardiovascular malformation, and hemihyperplasia. Be-
cause of the small number of reported cases it is difficult
to judge whether these malformations are related to the
chromosomal aberration or just coincidences.
Recurrent upper respiratory tract infection is a common
feature in males with int22h1/int22h2-mediated Xq28 du-
plication syndrome occurring in 5/9 previously reported
males and in all the five males in this report. We have per-
formed immunological evaluation for these 5 males, how-
ever, the results did not show any significant abnormalitiesexcluding major defects in cellular immunity and antibody
production.
The int22h1/int22h2-mediated Xq28 duplications were
confirmed to be maternally inherited in all previously re-
ported families except one family in which the mother
refused blood sampling [7-9]. In families 1, 2, and 5 in
this report the duplications were also confirmed to be
maternally inherited, whereas the mothers in families 3
and 4 were unavailable for testing. Therefore, this dupli-
cation has been shown to be maternally inherited for all
the subjects reported so far whose mothers were tested.
XCI analyses performed in the 6 previously reported fe-
males and the 6 females in this report revealed skewed
XCI in 9 out of 12 females with int22h1/int22h2-mediated
Xq28 duplication (Table 2). XCI assays provided inconsist-
ent results regarding whether females with skewed XCI in-
activate the normal chromosome X or the one carrying
the duplication. Additionally, there has been no clear cor-
relation between the XCI pattern and the cognitive pheno-
types with random and skewed XCI occurring in both
cognitively normal and impaired females as detailed in
Table 2. Peripheral leukocytes are used for the XCI assays;
therefore, the results exclusively reflect the XCI status of
hematopoietic cells. It is possible that a different XCI pat-
tern occurs in the nervous system. Such tissue-specific
variation of XCI patterns may provide a feasible explan-
ation of the observed lack of correlation between the re-
sults of XCI pattern in leukocytes and the cognitive
phenotype [16,18]. A possible explanation for the incon-
sistent predictions of the inactivated chromosome X is the
occurrence of a recombination event between the tested
locus and the Xq28 duplication region which can result in
the translocation of the duplication region to the opposite
allele yielding results contrary to the actual situation.
The duplication breakpoints are localized to the
directly-oriented LCRs int22h1 located within intron 22
of the F8 gene and int22h2 situated ~0.5 kb telomeri-
cally to int22h1. A third homologous region int22h-3 is
located ~0.6 kb telomerically to int22h1. Genomic inver-
sions between int22h-1 and either int22h-2 or int22h-3,
disrupts the F8 gene in nearly half of severe hemophilia
A cases [19]. However, int22h1/int22h2-mediated Xq28
duplication does not result in hemophilia A because a
complete copy of F8 gene is preserved after formation of
this duplication [7]. None of the individuals reported
here with int22h1/int22h2-mediated Xq28 duplication
demonstrated any bleeding tendency.
In addition to part of F8 which encodes the coagulation
factor VIII, other genes in the ~0.5 Mb duplicated region
between int22h1 and int22h2 are: FUNDC2, CMC4,
MTCP1, BRCC3,VBP1, RAB39B, and CLIC2 (Figure 2). The
cognitive impairment in individuals with int22h1/int22h2-
mediated Xq28 duplication is likely due to increased dosage
of one or more of the genes in the duplicated region
Figure 2 Schematic representation of the Xq28 region (154.0 – 155.3 Mb). Duplications are displayed as gray and deletions as white rectangles.
Genes in the int22h-1/int22h-2-mediated Xq28 rearrangement region are displayed at the upper panel. The nucleotide position numbers are in Mb
based on hg19. Andersen et al. 2014 is reference [26], Janczar et al. 2014 is reference [28], and Miskinyte et al. 2012 is reference [27].
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candidate gene is RAB39B. The RAB39B gene encodes a
member of the Rab protein family, which are small GTPases
involved in intracellular signaling proteins that coordinate
vesicle trafficking during a variety of cellular processes, in-
cluding neuronal development and signaling [20,21]. Loss-
of-function mutations in RAB39B have been identified in
families with XLID. It has also been demonstrated in mouse
model that knocking down of Rab39b in primary hippocam-
pal neurons impairs synapse formation and neuronal differ-
entiation and maturation indicating a key role for RAB39B
in normal neuronal functioning [22]. On the other hand,
RAB39B overexpression was found in 2 subjects with
int22h1/int22h2-mediated Xq28 duplication. Overexpres-
sion of Rab39b in mouse primary hippocampal neurons re-
sults in decreased neuronal branching and synapse number,
suggesting that the increased dosage of RAB39B causes a
disturbed neuronal development [9]. Another candidate
gene that may contribute to the phenotype is CLIC2. The
CLIC2 gene encodes chloride intracellular channel 2
(CLIC2) protein that functions as an intrinsic stabilizer of
ryanodine receptors (RyR) therefore it can modulate calcium
signaling through the regulation of RyR channel activity
[23,24]. A missense mutation in CLIC2 was reported in two
brothers with cognitive impairment, seizures and cardiac
anomalies [25]. The suggestion of RAB39B and CLIC2 being
responsible for the observed phenotype in int22h1/int22h2-
mediated Xq28 duplication syndrome is further supported
by the identification of an overlapping ~0.8 Mb duplication
in Xq28 in individuals having clinical features similar to
those observed in int22h1/int22h2-mediated Xq28 duplica-
tion syndrome [26]. This ~0.8 Mb Xq28 duplication (154.4
– 155.2 Mb, hg19) overlaps with the int22h1/int22h2-mediated Xq28 duplication in a region that only harbors
RAB39B and CLIC2 (Figure 2), and has recently been re-
ported in three siblings with cognitive impairment, be-
havioral problems (ADHD and aggressiveness), short
stature, and distinctive facial features including high
forehead, hypertelorism, broad nasal bridge, thin upper
lip, and cupped ears. The three siblings had an add-
itional deletion that removes a segment of the pseu-
doautosomal region of Xp22.33 including SHOX
explaining the observed short stature in these siblings
[26]. The considerable phenotypic overlap between
these siblings with this ~0.8 Mb Xq28 duplication and
individuals with int22h1/int22h2-mediated Xq28 duplica-
tion suggests that the genes within the shared region,
RAB39B and CLIC2, contribute to the phenotype in both
groups [26].
The mother and daughter in family 6 with the reciprocal
int22h-1/int22h-2-mediated Xq28 deletion had extremely
skewed XCI patterns and normal cognition, supporting the
idea that this deletion has no phenotypic effect in females
[7]. The proband in family 7 is the first reported case with
prenatally diagnosed and de novo int22h1/int22h2-medi-
ated deletion. This infant adds more evidence to the benign
nature of this deletion in females. Females carrying the
int22h1/int22h2-mediated Xq28 deletions should not ex-
hibit clinical signs of hemophilia A as a result of the prefer-
ential inactivation of the chromosome X harboring the F8
gene-inclusive deletion [7]. None of the individuals in fam-
ilies 6 and 7 show any signs of bleeding tendency support-
ing that.
It has been also suggested that the int22h-1/int22h-2-me-
diated Xq28 deletion is embryonic lethal in males resulting
in higher miscarriage rates in females carrying this deletion
El-Hattab et al. BMC Medical Genetics  (2015) 16:12 Page 11 of 12[7]. The previously reported mother with this deletion had
two spontaneous miscarriages [7] and the mother of family
6 had one spontaneous miscarriage, which may be related
to the deletion. The proposed lethality in male embryos car-
rying the deletion suggests that one or more of the genes in
the deleted region (F8, FUNDC2, CMC4, MTCP1, BRCC3,
VBP1, RAB39B, and CLIC2) may be very essential for early
development and the hemizygous loss of this or these genes
is incompatible with life. Deletions including FUNDC2,
CMC4, MTCP1, and BRCC3 were reported in individuals
with syndromic Moyamoya disease, characterized by angio-
pathy, short stature, and distinctive facial features (Figure 2)
[27]. Recently, an ~150 kb deletion of Xq28 encompassing
part of F8, FUNDC2, CMC4, MTCP1, and BRCC3 was re-
ported in a child with severe hemophilia A, Moyamoya dis-
ease, and distinctive facial features (Figure 2) [28]. These
two reports provide evidence that the loss of these 5 genes
is compatible with life. From the remaining three genes,
loss-of-function mutations in both RAB39B and CLIC2
have been reported in individuals with cognitive impair-
ment making it less likely that the hemizygous loss of these
genes results in the lethality in males with int22h1/int22h2-
mediated deletion [22,25]. The remaining gene is VBP1
which encodes the Von Hippel-Lindau binding protein-1
(VBP1). Studies of double-stranded RNA interference in C.
elegans against VBP1 messenger resulted in an arrest of
embryogenesis at morula stages, suggesting that this protein
is necessary for morphogenesis [29]. Therefore, the hemizy-
gous loss of VBP1 may be the most likely cause of male
embryonic lethality in int22h1/int22h2-mediated deletion.
Conclusions
In conclusion, int22h1/int22h2-mediated Xq28 duplication
causes a recognizable syndrome in males, with females exhi-
biting milder phenotypes. Cognitive impairment occurs in
all males. Common features in males are behavioral prob-
lems, recurrent upper respiratory tract infections, and dis-
tinctive facial features. This duplication has been shown to
be maternally inherited for all the subjects whose mothers
were tested. Skewed XCI has been observed in the majority
of females carrying the duplication. Increased dosage of one
or more of the genes in the duplicated area may alter neur-
onal homeostasis, resulting in the observed cognitive impair-
ment. RAB39B and possibly CLIC2 are the most likely
candidate genes in which mutations have been reported
in individuals with cognitive impairment. The reciprocal
int22h1/int22h2-mediated Xq28 deletion results in ex-
tremely skewed XCI patterns and no clinical phenotype
in females. It is suggested that this deletion is embryonic
lethal in males; therefore females carrying this deletion
may be at higher risk of miscarriages.
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